Regulation of LRRK2 by Phosphatases
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-49969-7_8
Reference50 articles.
1. Taymans J (2014) Can the increasing number of newly developed leucine-rich repeat kinase 2 inhibitors validate or invalidate a potential disease-modifying therapeutic approach for Parkinson’s disease? Expert Opin Ther Pat 24:727–730. doi: 10.1517/13543776.2014.915945
2. Galatsis P, Henderson JL, Kormos BL, Hirst WD (2014) Leucine-rich repeat kinase 2 (LRRK2) inhibitors. Top Med Chem 18:111–148. doi: 10.1007/7355_2014_69
3. Taymans JM, Greggio E (2016) LRRK2 kinase inhibition as a therapeutic strategy for Parkinson’s disease, where do we stand? Curr Neuropharmacol 14(3):214–225
4. Tsika E, Moore DJ (2013) Contribution of GTPase activity to LRRK2-associated Parkinson disease. Small GTPases 4:164–170. doi: 10.4161/sgtp.25130
5. Taymans J-M (2012) The GTPase function of LRRK2. Biochem Soc Trans 40:1063–1069. doi: 10.1042/BST20120133
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively;Cells;2022-03-17
2. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation;Brain Research;2022-03
3. Identification of peptides interfering with the LRRK2/PP1 interaction;PLOS ONE;2020-08-13
4. Leucine‐rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease;Journal of Neurochemistry;2019-11-24
5. Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced Neurotoxicity;NeuroMolecular Medicine;2019-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3